微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 9.01% | 73.27% | 403.35% | 32/159 | 4.13% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.79% | -1.1% | -17.51% | 88/159 | 2.59% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.17% | 171.25% | -71.22% | 55/159 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 7.54% | 130.58% | 45% | 42/159 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.2% | 42.08% | 187.29% | 67/159 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.81% | 3.43% | 126.25% | 87/159 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.8% | -13.04% | -75.54% | 99/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 3.27% | 161.6% | -10.66% | 88/159 | 0.78% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.66% | -62.5% | 109.14% | 76/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.75% | 94.44% | 90.22% | 95/159 | 2.25% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.92% | -90.24% | -26.4% | 95/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.25% | -77.52% | -87.19% | 105/159 | 0.9% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.76% | -38.27% | 984.44% | 34/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.9% | -81.17% | -90.46% | 111/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 9.43% | 78.94% | 69.6% | 3/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 5.56% | -53.2% | -64.83% | 80/159 | 3.73% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 15.81% | -12.22% | 230.75% | 15/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.78% | -7.36% | -9.3% | 58/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 5.27% | 116.87% | -55.64% | 10/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.88% | 83.33% | -34.04% | 45/159 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 18.01% | 23.02% | 249.03% | 8/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.16% | 100.78% | 112.35% | 47/159 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.43% | -18.18% | -62.5% | 46/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.48% | 39.35% | -55.74% | 73/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 14.64% | 57.42% | 469.65% | 12/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.57% | -41.06% | -13.47% | 76/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.97% | 56.32% | -36.13% | 31/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.65% | -59.71% | -50% | 89/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.3% | -38.04% | 113.3% | 36/159 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.36% | -32.3% | 129.47% | 55/159 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.9% | -6.4% | -83.54% | 46/159 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.54% | -17.22% | -23.12% | 46/159 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 15.01% | 16.27% | 133.07% | 12/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 6.44% | -21.46% | 217.24% | 31/159 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.03% | -55.97% | -85.44% | 39/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 13.94% | -20.62% | 7.98% | 36/159 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 12.91% | -29.22% | 57.44% | 14/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 8.2% | -7.03% | 77.87% | 19/159 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.61% | 11.62% | -73.75% | 14/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 17.56% | -24.41% | -3.73% | 30/159 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 18.24% | -13.6% | 106.8% | 8/159 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 8.82% | -17.8% | 113.56% | 11/159 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 4.13% | -10.8% | -82.22% | 14/159 | 2.13% | 退市金泰 | 47.24% | 行业排名> |